Back to results
US 2026/0091052 A1Published application
Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome
AssigneeBeijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
InventorsChengyu JIANG, Jianchao DU, Zhu LIANG, Jiantao XU, Yan ZHAO
Life of this patent
Estimating the term…
Abstract
Provided are microRNA from a Rhodiola root and uses thereof in the prevention and/or the treatment of a fibroplasia medical sign and/or syndrome.
Claims19
A polynucleotide comprising:
- A) a sequence set forth in any one of SEQ ID NO:
- 1, 2, 3, 4, 5, 6, 7, 9, 10, 12, 13, 14, 15, 16 and 17, or a complementary sequence thereof;
- B) a sequence having at least 80%, 85%, 90%, 95%, 96%, 97% or 98% identity to the sequence set forth in A), and capable of preventing/treating fibrosis;
- C) a sequence hybridizing to the sequence set forth in A) under a stringent condition, and capable of preventing/treating fibrosis;
- D) a sequence obtained by adding, deleting, or substituting one or more nucleotides in the sequence set forth in A), and capable of preventing/treating fibrosis;
- or
- E) a precursor or modified variant of the sequence set forth in A), B), C) or D), and capable of preventing/treating fibrosis.
4 more elements
Dependencies are inferred from the claim text.